Evidence map›Paper›PMID 35765448›Full record

ArticleRSC advances2022

Molecular investigations on

Hrishikesh Gupta, Payal Gupta, Manikyaprabhu Kairamkonda, Krishna Mohan Poluri

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Biochemical and Physiological Profiles ofLife (Basel, Switzerland) · 2025
    Article
  2. Analyzing the impact of T7L variants overexpression on the metabolic profile of Escherichia coli.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hrishikesh GuptaDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee (IIT-Roorkee) Roorkee-247667 Uttarakhand India krishna.poluri@bt.iitr.ac.in mohanpmk@gmail.com.
Payal GuptaDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee (IIT-Roorkee) Roorkee-247667 Uttarakhand India krishna.poluri@bt.iitr.ac.in mohanpmk@gmail.com.
Manikyaprabhu KairamkondaDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee (IIT-Roorkee) Roorkee-247667 Uttarakhand India krishna.poluri@bt.iitr.ac.in mohanpmk@gmail.com.
Krishna Mohan PoluriDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee (IIT-Roorkee) Roorkee-247667 Uttarakhand India krishna.poluri@bt.iitr.ac.in mohanpmk@gmail.com.ORCID https://orcid.org/0000-0003-3801-7134
Indian Institute of Technology Roorkee · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prevalence of drug resistant

Identifiers

PMID35765448
PMCPMC9194923
OpenAlexW4283736305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.